Following pleasantly surprising Q3 results, Tilray shares outperformed those of industry peers on Wednesday. Despite the firm’s positive trading day, the MORE Act’s questionable prospects may be casting a shadow over the cannabis industry as a whole.
Videos & Articles help you expand your trading knowledge.
Our Economic calendar helps you explore global market events.
Understand the full costs of your trades now for better expense management later.
This information is written by Plus500 Ltd. The information is provided for general purposes only, and does not take into account any personal circumstances or objectives. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice. No representation or warranty is given as to the accuracy or completeness of this information. It does not constitute financial, investment or other advice on which you can rely. Any references to past performance, historical returns, future projections, and statistical forecasts are no guarantee of future returns or future performance. Plus500 will not be held responsible for any use that may be made of this information and for any consequences that may result from such use. Hence, any person acting based on this information does so at their own discretion. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research.
Cryptocurrency CFDs are not available to Retail Clients.
Plus500 uses cookies to improve your browsing experience. Click "Accept" to consent to all cookies or manage preferences on our cookie policy page.
